Cite
APA Citation
Ziff, M., Lawson, G., De-Silva, D., Cheesman, S., Kyriakou, C., Mahmood, S., Papanikolaou, X., Rabin, N., Sachchithananthan, S., Sive, J., Wechalekar, A., Yong, K., & Popat, R. (2021). ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set. Leukemia & lymphoma, 62(5), 1243–1246. http://access.bl.uk/ark:/81055/vdc_100129574126.0x000033